Martha D Port (Martha Port)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Patient Reported

Top Venues

The journal of headache and pain

This page only lists publications with an associated author ORCID identifier.

Publications

Richard B Lipton, Dawn C Buse, Claire H Sandoe, Janet H Ford, Austin L Hand, Jakub P Jedynak, Martha D Port, Holland C Detke
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study. Headache (2023)
Jessica Ailani, Dulanji K Kuruppu, Mallikarjuna Rettiganti, Tina Oakes, Krista Schroeder, Linda Wietecha, Martha D Port, Andrew M Blumenfeld
Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials. Headache 62 (2) (2022)
Janet H Ford, Tobias Kurth, Amaal J Starling, David W Ayer, Linda A Wietecha, Martha D Port, Mallikarjuna Rettiganti, Dustin D Ruff
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine. Headache 60 (10) (2021)
Li Shen Loo, Jessica Ailani, Jack Schim, Simin Baygani, Hans-Peter Hundemer, Martha D Port, John H Krege
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials. The journal of headache and pain 20 (1) (2019)